Ixazomib and Pevonedistat in Treating Patients With Multiple Myeloma That Has Come Back or Does Not Respond to Treatment
Clinical trial NCT03770260 · COMPLETED
Trial details
- NCT number
- NCT03770260
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-10
- Primary completion
- 2022-09-12
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.